Apyx Medical Corporation APYX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 25.59% | 18.22% | 9.86% | -1.32% | -5.14% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.59% | 18.22% | 9.86% | -1.32% | -5.14% |
| Cost of Revenue | 19.49% | 13.11% | 5.65% | -6.89% | -4.47% |
| Gross Profit | 29.39% | 21.42% | 12.55% | 2.33% | -5.55% |
| SG&A Expenses | 0.64% | -9.01% | -16.25% | -21.01% | -21.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.33% | -3.77% | -11.44% | -18.12% | -17.86% |
| Operating Income | 71.25% | 71.82% | 65.79% | 55.94% | 45.48% |
| Income Before Tax | 53.24% | 56.21% | 53.51% | 49.57% | 40.40% |
| Income Tax Expenses | 77.73% | 46.77% | 7.14% | 6.00% | 292.97% |
| Earnings from Continuing Operations | 51.37% | 54.94% | 52.86% | 49.08% | 39.27% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -758.82% | -189.42% | -210.42% | -119.51% | -68.22% |
| Net Income | 49.97% | 54.24% | 52.22% | 48.88% | 39.16% |
| EBIT | 71.25% | 71.82% | 65.79% | 55.94% | 45.48% |
| EBITDA | 76.56% | 75.60% | 68.26% | 57.41% | 46.40% |
| EPS Basic | 55.34% | 59.76% | 58.75% | 55.60% | 44.85% |
| Normalized Basic EPS | 56.21% | 60.46% | 58.98% | 50.51% | 39.27% |
| EPS Diluted | 55.34% | 59.76% | 58.75% | 55.60% | 44.85% |
| Normalized Diluted EPS | 56.21% | 60.46% | 58.98% | 50.51% | 39.27% |
| Average Basic Shares Outstanding | 10.49% | 12.92% | 15.63% | 15.76% | 11.36% |
| Average Diluted Shares Outstanding | 10.49% | 12.92% | 15.63% | 15.76% | 11.36% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |